LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings563 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
281.4M$1.5B8.4%———
Decreased
0
93.6M$944.3M5.3%———
Increased
62
84.3M$595.4M3.3%———
Decreased
0
239.9M$488.6M2.7%———
Unchanged
0
130.5M$346.5M1.9%———
Increased
49
??MKS INC.
Bond
198.9M$329.8M1.8%———
Decreased
0
83.5M$281.2M1.6%———
Increased
49
275.6M$275.9M1.5%———
New
70
239M$268.5M1.5%———
Increased
54
249.4M$257.9M1.4%———
Unchanged
0
293.1M$244.7M1.4%———
Increased
66
253.8M$243.7M1.4%———
New
70
259.6M$242.7M1.4%———
Increased
49
193.8M$242.4M1.4%———
Increased
50
236.6M$227.5M1.3%———
Increased
55
92.7M$226.4M1.3%———
Decreased
0
132.7M$225.4M1.3%———
New
70
182.4M$210.2M1.2%———
Decreased
0
172.6M$205.8M1.2%———
Increased
54
??ASCENDIS PHARMA ADelisted
Bond
139.6M$205.5M1.2%———
Increased
49
$17.9B
AUM
563
Positions
Q1 2026
Filing
Rating · 2.0
Quarterly Portfolio Change
+15%Q4'24$12.1B+22%Q1'25$14.7B+10%Q2'25$16.3B-8%Q3'25$15B+8%Q4'25$16.2B+10%Q1'26$17.9B
Activity profile
$ moved · Q1'26
New32%Increased19%Decreased27%Exited23%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.5 quarters
<1Q21%1-4Q45%1-2Y17%2Y+17%

LINDEN ADVISORS LP manages $17.9B across 563 positions as of Q1 2026. Top holdings: LUMENTUM HLDGS INC (8.4%), LUMENTUM HLDGS INC (5.3%), LUMENTUM HLDGS INC (3.3%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2026 Summary

Active quarter - 121 new positions, 69 exits, 55 increased. No standout high-conviction moves this quarter. Portfolio: $17.9B across 563 positions.

Portfolio Allocation

Top holdings by portfolio weight

Total AUM$18B
LUMENTUM HLD8.43%
LUMENTUM HLD5.29%
LUMENTUM HLD3.33%
CENTRUS ENER2.74%
APPLIED DIGI1.94%
MKS INC.1.85%
SPHERE ENTER1.57%
UNITY SOFTWA1.54%
BRIDGEBIO PH1.50%
LIBERTY MEDI1.44%
Other1.37%
Sector Breakdown

Portfolio allocation by GICS sector

Sectors6
Financial Services77.25%
Unknown20.51%
Energy1.70%
Consumer Cyclical0.29%
Utilities0.20%
Communication Services0.05%
Fund DNA

Behavioral investing profile

Checking access…
Momentum Trader
Compare DNA across all funds
Fund Rating
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record61
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

HBK INVESTMENTS L PHBK INVESTMENTS L P
$8.5B
PICTON MAHONEY ASSET MANAGEMENTPICTON MAHONEY ASSET MANAGEMENT
$10.8B
Checking access…

Explore More

Compare LINDEN ADVISORS LP
Side-by-side holdings comparison
High-Conviction Picks
Top conviction positions this quarter
Double-Down Detection
Buying into price weakness
Best Trades
Top performing positions by P&L
All Momentum Trader Funds
Investing archetypes and behavior

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q3 2024 → Q2 2026+157.4M shares+$200.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 → Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 → Q2 2026+26.6M shares+$50.6M
Checking access…

Continue exploring

Explore high-conviction positions
See which stocks have the strongest institutional commitment
Compare with similar funds
Find portfolio overlap with LINDEN ADVISORS LP
Clone this fund
Backtest what copying LINDEN ADVISORS LP's portfolio would return

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used